ResApp Appoints Michael Stein as Non-Executive Director
April 05, 2020 at 07:02 pm
ResApp Health Limited announced the appointment of Dr Michael Stein as a Non-Executive Director, effective immediately. Michael is currently acting CEO of immuno-oncology company, Valo Therapeutics. Immediately prior to Valo, Michael was the founding CEO of OxStem Ltd, an award-winning biotechnology spin-out from the University of Oxford.